Thought Leadership

Tap our storehouse of insights and expertise

A key focus of our mission at Emergent CDMO is to speed the development and delivery of essential vaccines and therapeutics to the patients who need them. To support that goal, we’ve created a blog in which Emergent’s team of experts shares ideas, information, and insights with the biopharma community. This series covers a range of subjects relevant to our industry, including emerging tools and technologies, best practices, and lessons learned that can help you and your team move forward.

We hope you find this series userful and invite you to get in touch with any questions or suggestions you might have for future topics.

11.30.2023

3 Things Manufacturers Need to Know About the New Annex 1 Revision

In August 2023, long-awaited drug manufacturing regulations took effect with the implementation of the European Commission’s...

10.26.2023

Key Considerations When Partnering with a CDMO for Your Plasma-Derived Therapies

Plasma contains an array of beneficial constituents that, when purified and concentrated, can be administered as medicines to...

06.28.2023

4 Steps for a Smooth Tech Transfer When Working with a CDMO

In our recent article with BioPharma Dive, Emergent's Shelly Buhay, Director of MS&T and Dan Perrin, Director of Manufacturing...

03.22.2023

How to Mitigate Risk for Biologics During Fill/Finish Manufacturing

As more biologics move through research and development, the demand for specialized aseptic fill/finish services has steadily...

11.02.2022

The Demand for Nanoparticles in Drug Formulation is Rising

Demand for nanoparticles in the biopharmaceutical industry is on the rise. Production of these tiny particles, which can protect...

10.04.2022

Focus on Fill and Finish

Kelly Christiansen, vice president & general manager of Emergent CDMO's Rockville drug product manufacturing facility recently...